Ayala Pharmaceuticals Inc (fka ADXS)

[oakrock]

Upcoming things to look forward to....



Anticipated Milestones Over the Next 12 Months with
TARGET
ADXS-HPV (axalimogene filolisbac) • Announce planned Investigator Sponsored Trial in Head and Neck Cancer Q4 2018
ADXS-HOT Prostate • IND Submission Q4 2018
ADXS-PSA • MetastaticProstatePh1/2Combinationwithpembrolizumab-- Part B Monotherapy Combination Therapy Data (12-mo PFS and OS) Q1 2019
ADXS-NEO • Clinical data from initial cohort (safety, immune response) 1H 2019
ADXS-HOT NSCLC • Clinical data from initial cohort (safety, immune response) 1H 2019
ADXS-HOT Bladder • IND Submission 2019
ADXS-HOT Construct #4 • IND Submission
Selected from Breast, ovarian, MSS-CRC, H&N 2019